Biologix is a pioneering pharmaceutical company dedicated to bringing innovative drugs to the Middle East and North Africa (MENA) region. Strategically located across 17+ key locations including the Gulf Cooperation Council (GCC), Egypt, North Africa, and the Levant, we specialize in the regional distribution and promotion of cutting-edge products and solutions for difficult-to-treat diseases.
As a privately-owned pharmaceutical enterprise operating under the laws of the United Arab Emirates (UAE), Biologix provides comprehensive, end-to-end solutions. Our services span from the pre-registration phase through to commercial-scale market access and risk management. We are committed to advancing healthcare in the MENA region by ensuring access to the latest and most effective treatments.
With a strong focus on quality standards, research and development, and sustainable practices, Biologix strives to meet the evolving needs of multinational pharmaceutical manufacturers. Our deep industrial expertise and understanding of the local market dynamics enable us to deliver exceptional value to our partners and patients.
Biologix provides end-to-end pharmaceutical solutions, including pre-registration support, market access strategies, regional distribution, and risk management.
Biologix is headquartered in Dubai Airport Free Zone, Dubai, United Arab Emirates, with a presence in 17+ key locations across the MENA region.
Biologix specializes in the distribution and promotion of innovative products and solutions for difficult-to-treat diseases.
Biologix assists multinational pharmaceutical manufacturers by facilitating market entry, ensuring regulatory compliance, and maximizing market access in the MENA region.
Yes, Biologix is committed to the highest quality standards, ensuring that all processes and products meet stringent regulatory requirements.
Biologix typically operates from 08:00 to 17:00 from Monday to Friday, and 08:00 to 13:00 on Saturday.
You can contact Biologix via email at info@biologixpharma.com or by phone at +97142997171.
Yes, Biologix invests in research and development to stay at the forefront of pharmaceutical innovation and provide cutting-edge solutions.
Biologix serves the Middle East and North Africa (MENA) region, including the Gulf Cooperation Council (GCC), Egypt, North Africa, and the Levant.
Yes, Biologix is dedicated to sustainable practices in all operations to minimize environmental impact and contribute to a healthier future.